ACUTE MYELOID LEUKEMIA IN REMISSION
Clinical trials for ACUTE MYELOID LEUKEMIA IN REMISSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA IN REMISSION trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine could shield transplant patients from deadly virus
⭐️ VACCINE ⭐️ OngoingThis study tests a vaccine designed to protect people who have had a stem cell transplant from a common virus called CMV. The virus can cause serious illness in those with weak immune systems. The vaccine uses a harmless virus to teach the body to fight CMV, aiming to reduce infe…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 19, 2026 12:01 UTC
-
New drug combo aims to tame stem cell Transplant's worst side effect
Disease control OngoingThis study tests whether adding a drug called cyclophosphamide after a stem cell transplant can reduce the risk of graft-versus-host disease (GVHD), a serious complication where donor cells attack the patient's body. The trial includes 35 adults with various blood cancers who are…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
Promising combo aims to stop AML from coming back
Disease control OngoingThis study tests whether a combination of two chemotherapy drugs, azacitidine and venetoclax, can help keep acute myeloid leukemia (AML) from returning in patients who are already in remission. About 50 adults whose leukemia is in first remission but who are not ready for a stem …
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
New combo before transplant aims to beat High-Risk leukemia
Disease control TerminatedThis study is for people with high-risk acute leukemia or myelodysplastic syndrome (MDS). It tests a new way to prepare the body for a donor stem cell transplant by combining targeted radiation (TMLI) with two chemotherapy drugs. The goal is to find the safest dose that can kill …
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 05:44 UTC
-
New transplant technique aims to cut deadly immune reaction in half-matched donors
Disease control OngoingThis study tests a stem cell transplant method that filters out certain immune cells (TCRαβ+ and CD19+) from a half-matched family donor's blood. The goal is to lower the risk of graft-versus-host disease, a serious complication, and allow patients to avoid long-term immune-suppr…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for older leukemia patients: drug may keep cancer away after transplant
Disease control OngoingThis study tests whether the drug ruxolitinib can help prevent acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) from coming back after a stem cell transplant. It includes older adults whose cancer is in remission. The goal is to improve survival and reduce complicat…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Donor vaccine could shield transplant patients from dangerous virus
Prevention OngoingThis early-phase trial tests whether giving a CMV vaccine to stem cell donors can boost the recipient's immunity after transplant. About 34 blood cancer patients receiving donor stem cells are involved. The goal is to prevent CMV viremia, a common and serious viral infection, wit…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated May 26, 2026 05:48 UTC
-
New blood test may predict leukemia return after transplant
Knowledge-focused OngoingThis study looks at whether a sensitive blood test can predict if acute myeloid leukemia (AML) will come back after a stem cell transplant. Researchers will follow 303 adults with AML in remission who are getting a transplant. The goal is to see if the test can help doctors catch…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Knowledge-focused
Last updated May 26, 2026 05:49 UTC